SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) ~~OF THE~~

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) ~~January~~March 262, 2021

VARIAN MEDICAL SYSTEMS, INC. ~~(Exact Name of Registrant as Specified in its Charter)~~

Delaware			1-7598			94-2359345
(State or Other Jurisdictionof Incorporation)			(Commission FileNumber)			(IRS Employer Identification No.)

(Exact Name of Registrant as Specified in its Charter)

3100 Hansen Way,		Palo Alto		CA	94304-1030
Delaware	1-7598		94-2359345
(Address of Principal Executive Offices)					(Zip Code)
(State or Other Jurisdiction of Incorporation)	(Commission File Number)		(IRS Employer Identification No.)

Registrant's telephone number, including area code (650) 493-4000


3100 Hansen Way, Palo Alto, CA		94304-1030
(Address of Principal Executive Offices)		(Zip Code)

~~Not~~Registrant’s ~~Applicable~~telephone ~~(Former Name or Former Address~~number, ifincluding ~~Changed~~area ~~Since~~code ~~Last Report~~(650) 493-4000

~~Check~~Not the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered:
Title of each class:	Trading Symbol(s)		Name of each exchange on which registered:
Common Stock, $1 par value	VAR	~~VAR~~	New York Stock Exchange	~~New York Stock Exchange~~

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended ~~transition~~transaction period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 25.02. ~~Results~~Departure of ~~Operations~~Directors ~~and~~or ~~Financial~~Certain ~~Condition~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

OnAs ~~January~~previously announced, on August 262, ~~2021~~2020, Varian Medical Systems, Inc., a Delaware corporation (the “Company”), ~~issued~~Siemens aHealthineers ~~press~~Holding ~~release~~I ~~announcing~~GmbH, ~~its~~a ~~preliminary~~company ~~results~~organized ofunder ~~operations for~~ the ~~three~~laws ~~months~~of ~~ended~~Germany ~~January 1~~(“Parent”), ~~2021~~Falcon Sub Inc. A, ~~copy~~a Delaware corporation and a direct wholly-owned subsidiary of ~~the~~Parent ~~press~~(“Merger ~~release~~Sub”), isand, ~~attached~~with asrespect ~~Exhibit~~to 99certain provisions, Siemens Medical Solutions USA, Inc.1., Aa ~~slide~~Delaware ~~presentation~~corporation, entered into an Agreement and Plan of Merger, pursuant to which, ~~includes~~on ~~supplemental~~the ~~information~~terms ~~relating~~and subject to the ~~Company,~~conditions isset ~~attached~~forth astherein, ~~Exhibit~~among ~~99.2.~~other ~~The~~things, ~~exhibits~~Merger Sub will be ~~posted~~merged onwith and into the Company's ~~website~~(the at“Merger”), ~~www.varian.com~~with ~~under~~the Company surviving the ~~"Investors"~~Merger ~~section~~as a wholly owned subsidiary of Parent.

~~The~~On ~~information furnished under Item~~ March 2~~.02~~, of2021, ~~this~~the ~~Current~~Company ~~Report~~announced onthat ~~Form~~Dow ~~8-K~~Wilson, ~~including~~ the ~~exhibits,~~Company’s ~~shall~~Chief ~~not~~Executive beOfficer, ~~deemed~~will ~~"filed"~~be ~~for~~departing ~~purposes~~the ofCompany ~~Section~~at 18the closing of the ~~Securities~~Merger ~~Exchange~~and ~~Act~~will ofserve ~~1934,~~ as ~~amended~~a ~~(the~~special ~~"Exchange~~advisor ~~Act"),~~to ~~nor~~Siemens ~~shall~~Healthineers itAG. beIn ~~deemed~~addition, ~~incorporated~~J. byMichael ~~reference~~Bruff, ~~into~~ the Company’s ~~filings~~Chief ~~with~~Financial ~~the SEC under the Securities Act of 1933~~Officer, aswill ~~amended,~~be ordeparting the ~~Exchange~~Company ~~Act,~~at ~~except~~the asclosing ~~shall~~of bethe ~~expressly set forth by specific reference in such a filing~~Merger.

AAll ~~copy~~ of the ~~press~~foregoing ~~release~~officers isare ~~attached~~expected asto ~~Exhibit~~continue 99in their current roles through the closing of the Merger.1.

Item 7.01.

Regulation FD Disclosure.

On March 2, 2021, the Company issued a press release regarding the departure of the Company’s Chief Executive Officer described in Item 5.02, which press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.

Item 9.01.

Financial Statements and Exhibits.

(id) Exhibits.

99.1	Press Release, dated March 2, 2021.	~~Press Release dated January 26, 2021, entitled “Varian Reports Results for the First Quarter of Fiscal Year 2021."~~
99.2		Slide presentation providing supplemental information.
104	Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document.
104		Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~Varian~~Dated: ~~Medical Systems~~March 2, ~~Inc.~~2021 ~~By: /s/ J. Michael Bruff Name: J. Michael Bruff Title: Senior Vice President and Chief Financial Officer~~

~~Dated~~VARIAN MEDICAL SYSTEMS, INC. By: ~~January 26~~/s/ Michael D. Hutchinson Name: Michael D. Hutchinson Title: SVP, ~~2021~~Chief Legal Officer, Corporate Secretary

Filing Compare · VARIAN MEDICAL SYSTEMS INC